Back to Search
DR. RICHARD DAVID BELT JR. D.O.
D.O.
Internal Medicine Physician
NPI: 1275064263IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
R4340(KY)
Education
LAKE ERIE COLLEGE OF OSTEOPATHIC MEDICINE, ERIE
Class of 2017
Research & Publications (13)
Serum proteomic profiling and haptoglobin polymorphisms in patients with GVHD after allogeneic hematopoietic cell transplantation.
PMID 19379511·J Hematol Oncol·2009
8-other
Gemcitabine and pemetrexed administered in rapid sequence as front-line chemotherapy for advanced non-small-cell lung cancer: a phase II clinical trial.
PMID 19150937·Ann Oncol·2009
3-trial
Phase II trial of sunitinib in patients with metastatic colorectal cancer after failure of standard therapy.
PMID 17947727·J Clin Oncol·2007
3-trial
Acquired pure megakaryocytic aplasia: report of a single case treated with mycophenolate mofetil.
PMID 17301968·Am J Hematol·2007
5-case
Randomized phase III study of trastuzumab, paclitaxel, and carboplatin compared with trastuzumab and paclitaxel in women with HER-2-overexpressing metastatic breast cancer.
PMID 16782917·J Clin Oncol·2006
3-trial
Randomized phase II study of bortezomib alone and bortezomib in combination with docetaxel in previously treated advanced non-small-cell lung cancer.
PMID 17075122·J Clin Oncol·2006
3-trial
Destructive facial T-cell lymphoma: the difficulty in diagnosis of pyoderma-like processes.
PMID 15985028·Int J Dermatol·2005
5-case
A phase I/II study of LY900003, an antisense inhibitor of protein kinase C-alpha, in combination with cisplatin and gemcitabine in patients with advanced non-small cell lung cancer.
PMID 15447994·Clin Cancer Res·2004
3-trial
Fourteen-day CHOP supported with granulocyte colony-stimulating factor in patients with aggressive non-Hodgkin's lymphoma: results of a phase II study.
PMID 14556680·Clin Lymphoma·2003
3-trial
Correlation of p53 immunostaining in primary and residual ovarian cancer at the time of positive second-look laparotomy and its prognostic role: a Southwest Oncology Group ancillary study.
PMID 12468337·Gynecol Oncol·2002
3-trial
Liposome-encapsulated doxorubicin compared with conventional doxorubicin in a randomized multicenter trial as first-line therapy of metastatic breast carcinoma.
PMID 11815957·Cancer·2002
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- UNIVERSITY OF KENTUCKY 800 ROSE STREET
LEXINGTON, KY 40536 - Phone
- (859) 323-2636
Quick Facts
- NPI
- 1275064263
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 9
- Publications
- 13
Are you this provider?
Claim Your Profile